SAKAR HEALTHCARE
Back to Income Statement
|
SAKAR HEALTHCARE Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹153 Cr | ₹133 Cr | ₹128 Cr | ₹95 Cr | ₹8,298,024 Cr |
What is the latest Revenue of SAKAR HEALTHCARE ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹153 Cr |
| Mar2024 | ₹133 Cr |
| Mar2023 | ₹128 Cr |
| Mar2022 | ₹95 Cr |
| Mar2021 | ₹8,298,024 Cr |
How is Revenue of SAKAR HEALTHCARE Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹153 Cr | 14.99 | |
| Mar2024 | ₹133 Cr | 4.00 | |
| Mar2023 | ₹128 Cr | 35.35 | |
| Mar2022 | ₹95 Cr | -100.00 | |
| Mar2021 | ₹8,298,024 Cr | - | |
Compare Revenue of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,827.8 Cr | -0.4% | 2.5% | 134.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | -0.4% |
2.5% |
134.3% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses